Log in


Advancing translational life sciences research and academic technology transfer

  • Home
  • New Research Highlights a Rare Gene Mutation Linked to Cancer Risk in the Ashkenazi Jewish Population, The Wistar Institute

New Research Highlights a Rare Gene Mutation Linked to Cancer Risk in the Ashkenazi Jewish Population, The Wistar Institute

13 Aug 2020 10:00 AM | Anonymous

Dr. Maureen  Murphy, Ira Brind Professor and program leader of the Molecular & Cellular Oncogenesis Program of The Wistar Institute Cancer Center, has been investigating the importance of inherited mutations in the gene encoding p53 tumor suppressor protein to determine cancer susceptibility in people of African descent and people of Ashkenazi Jewish descent, for the past twenty-two years.

<<FULL STORY>>

Contact Us

admin@biostrategypartners.org
717-514-0436

P.O. Box 83 Boiling Springs, PA 17007



Copyright 2017, BioStrategy Partners. All rights reserved.   
Powered by Wild Apricot Membership Software